B-Raf serine-threonine kinase (BRAF) inhibitors
- Name
- B-Raf serine-threonine kinase (BRAF) inhibitors
- Accession Number
- DBCAT005747
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Vemurafenib A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. Dabrafenib A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. Encorafenib A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. - Drugs & Drug Targets